Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine

NCT00861406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Pegylated Interferon-Alfa 2b (PEG Intron)
DRUG: GP-100 Peptide Vaccine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]